Recruiting Lymphoma Studies in San Antonio
Evaluate the Safety and Clinical Activity of HH2853
This is an open-label, multicenter, first-in-human phase I/II study which is composed of 3 parts: phase I dose escalation, phase I dose extension and phase II. HH2853 will be administered orally on a ...
A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies
This is an open-label, multicenter, Phase 1/2 study evaluating the safety and efficacy of CTX112â„¢ in subjects with relapsed or refractory B-cell malignancies....
About Lymphoma Clinical Trials in San Antonio
Lymphoma is a cancer of the lymphatic system that affects infection-fighting cells called lymphocytes. The two main types are Hodgkin lymphoma and non-Hodgkin lymphoma. Treatment often includes chemotherapy, radiation, immunotherapy, and in some cases stem cell transplant.
There are currently 2 lymphoma clinical trials recruiting participants in San Antonio, TX. These studies are seeking a combined 374 participants. Research is being sponsored by Haihe Biopharma Co., Ltd., CRISPR Therapeutics AG. Clinical trial participation is free and participants receive study-related medical care at no cost.
Lymphoma Clinical Trials in San Antonio — FAQ
Are there lymphoma clinical trials in San Antonio?
Yes, there are 2 lymphoma clinical trials currently recruiting in San Antonio, TX. Browse the studies on this page to find one that fits.
How do I join a clinical trial in San Antonio?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the San Antonio research site will contact you about next steps.
Are clinical trials in San Antonio free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many San Antonio studies also compensate for your time and travel.
What lymphoma treatments are being tested?
The 2 active trials in San Antonio are testing new therapies including novel drugs, biologics, and treatment approaches for lymphoma.
Data updated March 2, 2026 from ClinicalTrials.gov